Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomized, placebo-controlled trial. ATS 2017, A7602.
Navulbare Respimat® wint Eco-Design Award
feb 2020 | Astma, COPD